Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Private employers may increasingly look to value-based insurance design (lower cost-share for high-value drugs) if convinced of long-term ROI
Triple-receptor binding profile distinguishes it from single-agonist and dual-agonist peptides
In the first trial, liraglutide lowered weight by 12 pounds and improved glucose tolerance relative to placebo over 4 months in 103 patients with schizophrenia spectrum disorders (Larsen JR et al, JAMA Psych 2017;74(1):719728)
You also talk about the systemic misunderstanding of obesity, and how the system, to quote you, caused our patients struggling with obesity and weight loss to become intensely distrustful of healthcare providers. How do you hope that, alongside the rise of these medications, we can rebuild trust between patients and providers
US$ 28.28
US$ 26.37
US$ 25.82
US$ 24.47
